UB-612

· Vaxxinity, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for UB-612, covering 2022-04-04 to 2022-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine [Phase 3]

See pricing